Zobrazeno 1 - 10
of 705
pro vyhledávání: '"Joseph S, Ross"'
Autor:
Yuan Lu, Ellen C. Keeley, Eric Barrette, Rhonda M. Cooper-DeHoff, Sanket S. Dhruva, Jenny Gaffney, Ginger Gamble, Bonnie Handke, Chenxi Huang, Harlan M. Krumholz, Caitrin W. McDonough, Wade Schulz, Kathryn Shaw, Myra Smith, Jennifer Woodard, Patrick Young, Keondae Ervin, Joseph S. Ross
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Improving hypertension control is a public health priority. However, consistent identification of uncontrolled hypertension using computable definitions in electronic health records (EHR) across health systems remains uncertain. M
Externí odkaz:
https://doaj.org/article/e304d9fa864d47d79b10019f10feec13
Autor:
Maryam Mooghali, Austin M. Stroud, Dong Whi Yoo, Barbara A. Barry, Alyssa A. Grimshaw, Joseph S. Ross, Xuan Zhu, Jennifer E. Miller
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Artificial intelligence (AI) is increasingly used for prevention, diagnosis, monitoring, and treatment of cardiovascular diseases. Despite the potential for AI to improve care, ethical concerns and mistrust in AI-enabled healthcar
Externí odkaz:
https://doaj.org/article/afb3b05e8e8a4264a514fb8f25b94967
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Introduction Real-world evidence is receiving considerable attention as a way to evaluate the efficacy and safety of medical products for substance use disorders (SUDs). However, the feasibility of using real-world data (RWD) to emulate clin
Externí odkaz:
https://doaj.org/article/f406de2a6b4c46ccb26cf319f629c067
Publikováno v:
BMJ Open, Vol 14, Iss 10 (2024)
Objectives To compare the premarket and postmarket evidence of safety and efficacy of direct oral anticoagulants approved for stroke prevention in atrial fibrillation patients across four major regulatory agencies.Design Cross-sectional.Setting Europ
Externí odkaz:
https://doaj.org/article/a2afb72fba054fbd818cc9fcf79d79d8
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
ABSTRACTBackground To reduce Medicare prescription drug expenditures, the 2022 Inflation Reduction Act (IRA) allows the Centers for Medicare & Medicaid Services (CMS) to directly negotiate with drug manufacturers on Medicare prices of high-expenditur
Externí odkaz:
https://doaj.org/article/48613d76179842769386dabc5fd08ca0
Autor:
Joseph S Ross, Jennifer Miller, Cary Gross, Reshma Ramachandran, Linda Gough, William Pelletiers, Sakinah Suttiratana, Michael Ofosu Mensah, Jason Schwartz
Publikováno v:
BMJ Medicine, Vol 3, Iss 1 (2024)
Objective To develop a reference standard based on US Food and Drug Administration and stakeholder guidance for pharmaceutical companies' policies on diversity in clinical trials and to assess these policies.Design Development of a reference standard
Externí odkaz:
https://doaj.org/article/81b55978402340978773f3ddc47c7c02
Autor:
Joseph S Ross, Joshua D Wallach, Ravi Gupta, Kai Chen, Kate Nyhan, Maryam Mooghali, Victoria L Bartlett, Harry Doernberg
Publikováno v:
BMJ Medicine, Vol 3, Iss 1 (2024)
Objective To better understand the state of research on the effects of climate change on human health, including exposures, health conditions, populations, areas of the world studied, funding sources, and publication characteristics, with a focus on
Externí odkaz:
https://doaj.org/article/7dcb4235319a46f690158c9811a99f82
Autor:
Joseph S Ross, Joshua D Wallach, Reshma Ramachandran, Vivien Chen, Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel
Publikováno v:
BMJ Medicine, Vol 3, Iss 1 (2024)
Objectives To evaluate National Comprehensive Cancer Network (NCCN) guideline recommendations for oncology drug treatments that have been granted accelerated approval, and to determine whether recommendations are updated based on the results of confi
Externí odkaz:
https://doaj.org/article/3a621357b0bc4da6bf97acef614755d4
Autor:
Evangelos K. Oikonomou, Phyllis M. Thangaraj, Deepak L. Bhatt, Joseph S. Ross, Lawrence H. Young, Harlan M. Krumholz, Marc A. Suchard, Rohan Khera
Publikováno v:
npj Digital Medicine, Vol 6, Iss 1, Pp 1-13 (2023)
Abstract Randomized clinical trials (RCT) represent the cornerstone of evidence-based medicine but are resource-intensive. We propose and evaluate a machine learning (ML) strategy of adaptive predictive enrichment through computational trial phenomap
Externí odkaz:
https://doaj.org/article/e5b6bceab7c2410fa2b117628815a86b
Autor:
Anisa Rowhani-Farid, Mikas Grewal, Steven Solar, Allen O. Eghrari, Audrey D. Zhang, Cary P. Gross, Harlan M. Krumholz, Joseph S. Ross
Publikováno v:
Scientific Data, Vol 10, Iss 1, Pp 1-8 (2023)
Abstract The impact and effectiveness of clinical trial data sharing initiatives may differ depending on the data sharing model used. We characterized outcomes associated with models previously used by the U.S. National Institutes of Health (NIH): Na
Externí odkaz:
https://doaj.org/article/5f5e5f0509374313b1084dac24569394